Homologous Recombination
CRISPR/Cas9 Genome Editing
CRISPR
Conservative Site-specific Recombination and Phase Variation
CRISPR and crRNAs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 2, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Xuan Yao1,2, Xing Wang1,2, Xinde Hu1
1Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
A new homology-mediated end joining (HMEJ) strategy enhances transgene integration efficiency. This CRISPR/Cas9-based method shows promise for gene editing in animal models and gene therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: